Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha

Virology

Volumn 444, Issue 1-2, 2013, Pages 317-328

  Pollicino, Teresa ^a   Bellinghieri, Luigi ^b   Restuccia, Agnese ^a,b   Raffa, Giuseppina ^a,b   Musolino, Cristina ^a,b   Alibrandi, Angela ^a   Teti, Diana ^b   Raimondo, Giovanni ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Chromatin immunoprecipitation; Chromatin modifying enzymes; Hepatitis B virus chronic infection; Hepatitis B X viral regulatory protein; IL 8 promoter; IL 8 siRNA; Interferon alpha; Interleukin 8; Signal pathways; Transcription factors

Indexed keywords

ALPHA INTERFERON; CCAAT ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; TRANSCRIPTION FACTOR AP 1; VIRUS DNA;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; HEPATITIS B VIRUS; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERLEUKIN 8 GENE; MALE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; TISSUE LEVEL; TRANSACTIVATION; UPREGULATION; VIRUS GENE; VIRUS IDENTIFICATION; VIRUS REPLICATION;

CHROMATIN IMMUNOPRECIPITATION; CHROMATIN MODIFYING ENZYMES; HEPATITIS B VIRUS CHRONIC INFECTION; HEPATITIS B X VIRAL REGULATORY PROTEIN; IL-8 PROMOTER; IL-8 SIRNA; INTERFERON-ALPHA; INTERLEUKIN-8; SIGNAL PATHWAYS; TRANSCRIPTION FACTORS;

ADULT; AGED; AGED, 80 AND OVER; CELL LINE; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-8; MALE; MIDDLE AGED; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 84882877800     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.06.028     Document Type: Article

References (55)

1. Ait-Goughoulte M., Lucifora J., Zoulim F., Durantel D. Innate antiviral immune responses to hepatitis B virus. Viruses 2010, 2(7):1394-1410.
2. Alcami A. Viral mimicry of cytokines, chemokines and their receptors. Nat. Rev. Immunol. 2003, 3(1):36-50.
3. Alcorn M.J., Booth J.L., Coggeshall K.M., Metcalf J.P. Adenovirus type 7 induces interleukin-8 production via activation of extracellular regulated kinase 1/2. J. Virol. 2001, 75(14):6450-6459.
4. Belloni L., Pollicino T., De Nicola F., Guerrieri F., Raffa G., Fanciulli M., Raimondo G., Levrero M. Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(47):19975-19979.
5. Bertoletti A., Maini M.K., Ferrari C. The host-pathogen interaction during HBV infection: immunological controversies. Antivir. Ther. 2010, 15(Suppl 3):15-24.
6. Biron C.A. Interferons alpha and beta as immune regulators--a new look. Immunity. 2001, 14(6):661-664.
7. Caristi S., Piraino G., Cucinotta M., Valenti A., Loddo S., Teti D. Prostaglandin E2 induces interleukin-8 gene transcription by activating C/EBP homologous protein in human T lymphocytes. J. Biol. Chem. 2005, 280(15):14433-14442.
8. Chen M.T., Billaud J.N., Sallberg M., Guidotti L.G., Chisari F.V., Jones J., Hughes J., Milich D.R. A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(41):14913-14918.
9. Chisari F.V., Ferrari C. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 1995, 13:29-60.
10. Cougot D., Wu Y., Cairo S., Caramel J., Renard C.A., Levy L., Buendia M.A., Neuveut C. The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription. J. Biol. Chem. 2007, 282(7):4277-4287.
11. Dienstag J.L. Hepatitis B virus infection. N. Engl. J. Med. 2008, 359(14):1486-1500.
12. Dunn C., Brunetto M., Reynolds G., Christophides T., Kennedy P.T., Lampertico P., Das A., Borrow P., Williams K., Humphreys E., Afford S., Adams D.H., Bertoletti A., Maini M.K., Lopes A.R. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J. Exp. Med. 2007, 204(3):667-680.
13. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J. Hepatol. 2012, 57(1):167-185. EASL.
14. Finlay B.B., McFadden G. Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell 2006, 124(4):767-782.
15. Gehring A.J., Koh S., Chia A., Paramasivam K., Chew V.S., Ho Z.Z., Lee K.H., Maini M.K., Madhavan K., Lim S.G., Bertoletti A. Licensing virus-specific T cells to secrete the neutrophil attracting chemokine CXCL-8 during hepatitis B virus infection. PLoS One 2011, 6(8):e23330.
16. Girard S., Shalhoub P., Lescure P., Sabile A., Misek D.E., Hanash S., Brechot C., Beretta L. An altered cellular response to interferon and up-regulation of interleukin-8 induced by the hepatitis C viral protein NS5A uncovered by microarray analysis. Virology. 2002, 295(2):272-283.
17. Green J., Khabar K.S., Koo B.C., Williams B.R., Polyak S.J. Stability of CXCL-8 and related AU-rich mRNAs in the context of hepatitis C virus replication in vitro. J. Infect. Dis. 2006, 193(6):802-811.
18. Guidotti L.G., Chisari F.V. Cytokine-mediated control of viral infections. Virology 2000, 273(2):221-227.
19. Herceg Z., Paliwal A. Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome. Mutat. Res. 2011, 727(3):55-61.
20. Hildt E., Munz B., Saher G., Reifenberg K., Hofschneider P.H. The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice. EMBO J. 2002, 21(4):525-535.
21. Hisatsune J., Nakayama M., Isomoto H., Kurazono H., Mukaida N., Mukhopadhyay A.K., Azuma T., Yamaoka Y., Sap J., Yamasaki E., Yahiro K., Moss J., Hirayama T. Molecular characterization of Helicobacter pylori VacA induction of IL-8 in U937 cells reveals a prominent role for p38MAPK in activating transcription factor-2, cAMP response element binding protein, and NF-kappaB activation. J. Immunol. 2008, 180(7):5017-5027.
22. Hoffmann E., Dittrich-Breiholz O., Holtmann H., Kracht M. Multiple control of interleukin-8 gene expression. J. Leukocyte Biol. 2002, 72(5):847-855.
23. Kakimi K., Lane T.E., Wieland S., Asensio V.C., Campbell I.L., Chisari F.V., Guidotti L.G. Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. J. Exp. Med. 2001, 194(12):1755-1766.
24. Kew M.C. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma. J. Gastroenterol. Hepatol. 2011, 26(Suppl 1):144-152.
25. Khabar K.S., Al-Zoghaibi F., Al-Ahdal M.N., Murayama T., Dhalla M., Mukaida N., Taha M., Al-Sedairy S.T., Siddiqui Y., Kessie G., Matsushima K. The alpha chemokine, interleukin 8, inhibits the antiviral action of interferon alpha. J. Exp. Med. 1997, 186(7):1077-1085.
26. Khabar K.S., Al-Zoghaibi F., Murayama T., Matsushima K., Mukaida N., Siddiqui Y., Dhalla M., Al-Ahdal M.N. Interleukin-8 selectively enhances cytopathic effect (CPE) induced by positive-strand RNA viruses in the human WISH cell line. Biochem. Biophys. Res. Commun. 1997, 235(3):774-778.
27. Kotwal G.J., Hatch S., Marshall W.L. Viral infection: an evolving insight into the signal transduction pathways responsible for the innate immune response. Adv. Virol. 2012, 2012:131457.
28. Lee C.M., Yen Y.H., Hung C.H., Lu S.N., Wang J.H., Wang J.C., Chen C.H., Kee K.M., Hu T.H., Changchien C.S. Liver interleukin-8 messenger RNA expression and interferon sensitivity-determining region mutations relate to treatment response in hepatitis C 1b. Antivir. Ther. 2011, 16(6):825-832.
29. Locarnini S., Shaw T., Dean J., Colledge D., Thompson A., Li K., Lemon S.M., Lau G.G., Beard M.R. Cellular response to conditional expression of the hepatitis B virus precore and core proteins in cultured hepatoma (Huh-7) cells. J. Clin Virol. 2005, 32(2):113-121.
30. Luster A.D Chemokines--chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 1998, 338(7):436-445.
31. Mahe Y., Mukaida N., Kuno K., Akiyama M., Ikeda N., Matsushima K., Murakami S. Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis-elements. J. Biol. Chem. 1991, 266(21):13759-13763.
32. Maini M.K., Boni C., Lee C.K., Larrubia J.R., Reignat S., Ogg G.S., King A.S., Herberg J., Gilson R., Alisa A., Williams R., Vergani D., Naoumov N.V., Ferrari C., Bertoletti A. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J. Exp. Med. 2000, 191(8):1269-1280.
33. Mukaida N. Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am. J. Physiol. Lung. Cell Mol. Physiol. 2003, 284(4):L566-577.
34. Murayama T., Kuno K., Jisaki F., Obuchi M., Sakamuro D., Furukawa T., Mukaida N., Matsushima K. Enhancement human cytomegalovirus replication in a human lung fibroblast cell line by interleukin-8. J. Virol. 1994, 68(11):7582-7585.
35. Park I.Y., Sohn B.H., Yu E., Suh D.J., Chung Y.H., Lee J.H., Surzycki S.J., Lee Y.I. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology 2007, 132(4):1476-1494.
36. Paschos K., Allday M.J. Epigenetic reprogramming of host genes in viral and microbial pathogenesis. Trends Microbiol. 2010, 18(10):439-447.
37. Perrillo R.P. Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease. Gastroenterology 2001, 120(4):1009-1022.
38. Pollicino T., Belloni L., Raffa G., Pediconi N., Squadrito G., Raimondo G., Levrero M. Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones. Gastroenterology 2006, 130(3):823-837.
39. Pollicino T., Raffa G., Costantino L., Lisa A., Campello C., Squadrito G., Levrero M., Raimondo G. Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. Hepatology 2007, 45(2):277-285.
40. Pollicino T., Squadrito G., Cerenzia G., Cacciola I., Raffa G., Craxi A., Farinati F., Missale G., Smedile A., Tiribelli C., Villa E., Raimondo G. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology 2004, 126(1):102-110.
41. Polyak S.J., Khabar K.S., Paschal D.M., Ezelle H.J., Duverlie G., Barber G.N., Levy D.E., Mukaida N., Gretch D.R. Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J. Virol. 2001, 75(13):6095-6106.
42. Polyak S.J., Khabar K.S., Rezeiq M., Gretch D.R. Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy. J. Virol. 2001, 75(13):6209-6211.
43. Rajaiya J., Xiao J., Rajala R.V., Chodosh J. Human adenovirus type 19 infection of corneal cells induces p38 MAPK-dependent interleukin-8 expression. Virol. J. 2008, 5:17.
44. Redpath S., Angulo A., Gascoigne N.R., Ghazal P. Immune checkpoints in viral latency. Annu. Rev. Microbiol. 2001, 55:531-560.
45. Rehermann B. Immune responses in hepatitis B virus infection. Semin. Liver Dis. 2003, 23(1):21-38.
46. Sitia G., Isogawa M., Iannacone M., Campbell I.L., Chisari F.V., Guidotti L.G. MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs. J. Clin. Invest. 2004, 113(8):1158-1167.
47. Tan A.T., Koh S., Goh W., Zhe H.Y., Gehring A.J., Lim S.G., Bertoletti A. A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B. J. Hepatol. 2010, 52(3):330-339.
48. Taub D.D., Anver M., Oppenheim J.J., Longo D.L., Murphy W.J. T lymphocyte recruitment by interleukin-8 (IL-8). IL-8-induced degranulation of neutrophils releases potent chemoattractants for human T lymphocytes both in vitro and in vivo. J. Clin. Invest. 1996, 97(8):1931-1941.
49. Venza I., Cucinotta M., Caristi S., Mancuso G., Teti D. Transcriptional regulation of IL-8 by Staphylococcus aureus in human conjunctival cells involves activation of AP-1. Invest. Ophthalmol. Vis. Sci. 2007, 48(1):270-276.
50. Visvanathan K., Skinner N.A., Thompson A.J., Riordan S.M., Sozzi V., Edwards R., Rodgers S., Kurtovic J., Chang J., Lewin S., Desmond P., Locarnini S Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 2007, 45(1):102-110.
51. Wagoner J., Austin M., Green J., Imaizumi T., Casola A., Brasier A., Khabar K.S., Wakita T., Gale M., Polyak S.J. Regulation of CXCL-8 (interleukin-8) induction by double-stranded RNA signaling pathways during hepatitis C virus infection. J. Virol. 2007, 81(1):309-318.
52. Walsh R., Locarnini S. Hepatitis B precore protein: pathogenic potential and therapeutic promise. Yonsei Med. J. 2012, 53(5):875-885.
53. Yu Y., Gong R., Mu Y., Chen Y., Zhu C., Sun Z., Chen M., Liu Y., Zhu Y., Wu J. Hepatitis B virus induces a novel inflammation network involving three inflammatory factors, IL-29, IL-8, and cyclooxygenase-2. J. Immunol. 2011, 187(9):4844-4860.
54. Zheng J.C., Huang Y., Tang K., Cui M., Niemann D., Lopez A., Morgello S., Chen S. HIV-1-infected and/or immune-activated macrophages regulate astrocyte CXCL8 production through IL-1beta and TNF-alpha: involvement of mitogen-activated protein kinases and protein kinase R. J. Neuroimmunol. 2008, 200(1-2):100-110.
55. Zimmermann H.W., Seidler S., Gassler N., Nattermann J., Luedde T., Trautwein C., Tacke F. Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PLoS One 2011, 6(6):e21381.